Mostrar el registro sencillo del ítem

dc.contributor.authorMárquez-Gómez, Javier 
dc.contributor.authorCardona Ramírez, Carolina
dc.contributor.authorAlonso-Carrión, Francisco José 
dc.contributor.authorLobo, Carolina
dc.contributor.authorCampos-Sandoval, José Ángel 
dc.contributor.authorMartín Rufián, Mercedes
dc.date.accessioned2013-10-25T06:51:23Z
dc.date.available2013-10-25T06:51:23Z
dc.date.issued2013
dc.identifier.urihttp://hdl.handle.net/10630/6155
dc.descriptionA proteomics study of the nuclear protein profiling of human glioblastoma cells with targeted glutaminase expression. The study was performed with protein microarrays and SELDI-TOF technology.es_ES
dc.description.abstractHuman glutaminase (GA) enzymes are the products of two genes, GLS and GLS2. GA isozymes play markedly different roles in tumour biology: GLS isoforms (KGA and GAC) are related to cell growth and proliferation, whereas GLS2 isoforms (GAB and LGA) are associated with low proliferation rates and are characteristics for resting or quiescent cells. Furthermore, the GAB isoform has been recently involved in transcriptional regulation. Due to the proposed roles of GAB isoform in cellular differentiation and transcriptional modulation, the aim of the present study is to profile differentially expressed nuclear proteins in order to discover putative biomarkers associated with GAB overexpression in glioma cells. Nuclear cell proteins were incubated with strong anion exchange (Q10) and weak cation exchange (CM10) ProteinChip arrays and analyzed using surface-enhanced laser desorption/ionization time-of- flight mass spectrometry (SELDI-TOF/MS) proteomics technology. T98G-GAB nuclear protein expression profiles were compared with those of T98G-WT and empty vector transfected T98G-pcDNA3 with the ProteinChip Data Manager Client 4.0 software. Eighteen proteins were found to be differentially expressed between control cells and GAB-transfected T98G cells. Nine proteins with m/z between 5.5-29.7 were identified to be highly expressed in T98G-GAB (P≤ 0.01), while the expression of two proteins with m/z values of 7.8 and 8.5 were higher in control cells (P≤ 0.01). Our study shows the potential of proteomics profiling to get a deep insight into the role of nuclear GAB in brain tumors in order to assess its suitability as a novel anti-cancer therapeutic target. References Pérez-Gómez C, et al. Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem. J. 2005; 386, 535-42. Szeliga M, et al. Transfection with liver-type glutaminase (LGA) cDNA alteres gene expression and reduces viability, migration and proliferation of T98G glioma cells. Glia 2009; 57, 1014-23.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.This work was supported by Grant SAF2010-17573 from the Ministry of Science and Innovation of Spain, Excellence Grant CVI-6656 from the regional Andalusian government (Junta de Andalucia), and Grant RD06/1012 of the RTA RETICS network from the Spanish Health Institute Carlos III.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectProteínases_ES
dc.subjectCánceres_ES
dc.subject.otherProteomicses_ES
dc.subject.otherProtein profilinges_ES
dc.subject.otherHuman glioblastomaes_ES
dc.subject.otherNuclear proteinses_ES
dc.subject.otherCánceres_ES
dc.subject.otherGlutaminasees_ES
dc.titleChanges in the nuclear proteomic profiling of human glioblastoma cells after glutaminase overexpressiones_ES
dc.typeinfo:eu-repo/semantics/conferenceObjectes_ES
dc.centroFacultad de Cienciases_ES
dc.relation.eventtitleFirst International Symposium on Profiling (ISPROF 2013)es_ES
dc.relation.eventplaceCosta de Caparica, Portugales_ES
dc.relation.eventdate2-4 Septiembre, 2013es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem